Depigmented and Polymerised Allergenic Extract of Dermatophagoides Pteronyssinus [house dust mite allergy vaccine] as Antiasthmatic Treatment for Children With Slight Allergic Asthma to Mites.
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2015
At a glance
- Drugs House dust mite allergy immunotherapy Laboratorios LETI (Primary) ; House dust mite allergy immunotherapy Laboratorios LETI (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Jan 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 05 Mar 2008 New trial record.